BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 64332)

  • 1. Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
    Owen LN; Briggs MH
    Curr Med Res Opin; 1976; 4(5):309-29. PubMed ID: 64332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary nodules in dogs during four years' treatment with megestrol acetate or chlormadinone acetate.
    Nelson LW; Weikel JH; Reno FE
    J Natl Cancer Inst; 1973 Oct; 51(4):1303-11. PubMed ID: 4126857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
    Frank DW; Kirton KT; Murchison TE; Quinlan WJ; Coleman ME; Gilbertson TJ; Feenstra ES; Kimball FA
    Fertil Steril; 1979 Mar; 31(3):340-6. PubMed ID: 437169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinology of reproduction in the female beagle dog and its significance in mammary gland tumorigenesis.
    Gräf KJ; El Etreby MF
    Acta Endocrinol Suppl (Copenh); 1979; 222():1-34. PubMed ID: 285559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
    Seibert B; Günzel P
    Contraception; 1994 Apr; 49(4):303-33. PubMed ID: 8013217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-year evaluation of the chronic toxicity of megestrol acetate in dogs.
    Weikel JH; Nelson LW; Reno FE
    Toxicol Appl Pharmacol; 1975 Sep; 33(3):414-26. PubMed ID: 52913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.
    Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W
    Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.
    Geil RG; Lamar JK
    J Toxicol Environ Health; 1977 Sep; 3(1-2):179-93. PubMed ID: 411941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestogens and mammary tumours in the beagle bitch.
    Briggs MH
    Res Vet Sci; 1980 Mar; 28(2):199-202. PubMed ID: 7414066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives, postmenopausal oestrogen-progestagen use and breast cancer.
    Gambrell RD
    J Obstet Gynaecol (Lahore); 1984 Apr; 4(Suppl 2):S121-7. PubMed ID: 12339859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose progestagens as contraceptive agents.
    Elstein M
    IPPF Med Bull; 1970; 4(1):2-4. PubMed ID: 12255089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of canine and human breast cancer.
    Owen LN
    Invest Cell Pathol; 1979; 2(4):257-75. PubMed ID: 396282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.